Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody-Reference-Cited by-同舟云学术

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

Published:2017-03-15 Issue:1 Volume:46 Page:89-94
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Abdolahpour Saeideh¹,Toliyat Tayebeh²,Omidfar Kobra³,Modjtahedi Helmout⁴,Wong Albert J.⁵,Rasaee Mohammad Javad⁶,Kashanian Susan¹,Paknejad Maliheh¹

Affiliation:

1. Department of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran;

2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;

3. Biosensor Research Center, Endocrinology and Metabolism Molecular and Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran;

4. School of Life Science, Faculty of Science, Engineering and Computing, Kingston University, London;

5. Brain Tumor Research Laboratories, Program in Cancer Biology, Stanford University Medical Center, Stanford, CA, USA;

6. Department of Medical Biotechnology, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran

Funder

Tehran University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2017.1296847

Reference40 articles.

1. Nanoparticle therapeutics: an emerging treatment modality for cancer

2. Nanocarriers as an emerging platform for cancer therapy

3. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances

4. In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide;Bioconjugate Chemistry;2024-08-24

2. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles;Life;2024-04-10

3. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting;International Journal of Pharmaceutics;2024-04

4. Surface Functionalized Lipid Nanoparticles in Promoting Therapeutic Outcomes: An Insight View of the Dynamic Drug Delivery System;Current Drug Targets;2024-03

5. Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy;Drug Delivery and Translational Research;2023-06-10